Jaguar Health (JAGX) Total Current Liabilities (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Total Current Liabilities of $40.7 million for Q1 2026, up 44.24% year-over-year from $28.2 million in Q1 2025, and little changed quarter-over-quarter from $40.7 million in Q4 2025.
Jaguar Health (JAGX) Total Current Liabilities (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Total Current Liabilities for 13 consecutive years, with $40.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 44.24% year-over-year to $40.7 million; the TTM figure through Mar 2026 stood at $40.7 million (up 44.24% YoY), while the FY2025 annual figure was $40.7 million, up 106.32% from the prior year.
- Total Current Liabilities was little changed at $40.7 million in Q1 2026 per JAGX's latest filing, from $40.7 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $40.7 million in Q1 2026 and bottomed at $12.5 million in Q3 2023.
- Historically, Total Current Liabilities has averaged $25.7 million across 5 years, with a median of $26.9 million in 2022.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 125.45% — and 2023, when it slumped 53.9%.
- Jaguar Health's Total Current Liabilities stood at $30.3 million in 2022, then plunged by 53.9% to $14.0 million in 2023, then surged by 40.87% to $19.7 million in 2024, then soared by 106.32% to $40.7 million in 2025, then climbed by 0.08% to $40.7 million in 2026.
- Business Quant data shows JAGX's Total Current Liabilities at $40.7 million in Q1 2026, $40.7 million in Q4 2025, and $36.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 630.93 Mn |
| 10 | Jaguar Health | 448,683.98 | -9.62 Mn | 19.11 Mn | 40.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.69 Mn |
| Dec 31, 2025 | 40.65 Mn |
| Sep 30, 2025 | 36.12 Mn |
| Jun 30, 2025 | 29.22 Mn |
| Mar 31, 2025 | 28.21 Mn |
| Dec 31, 2024 | 19.70 Mn |
| Sep 30, 2024 | 19.87 Mn |
| Jun 30, 2024 | 19.13 Mn |
| Mar 31, 2024 | 17.81 Mn |
| Dec 31, 2023 | 13.99 Mn |
| Sep 30, 2023 | 12.46 Mn |
| Jun 30, 2023 | 29.00 Mn |
| Mar 31, 2023 | 31.10 Mn |
| Dec 31, 2022 | 30.34 Mn |
| Sep 30, 2022 | 26.94 Mn |
| Jun 30, 2022 | 22.90 Mn |
| Mar 31, 2022 | 19.09 Mn |
| Dec 31, 2021 | 15.47 Mn |
| Sep 30, 2021 | 11.95 Mn |
| Jun 30, 2021 | 12.65 Mn |